Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Referrals Remove Referrals filter

Referral name

Referral status

European Commission final decision Remove European Commission final decision filter CMDh final position (17) Apply CMDh final position filter Under evaluation (1) Apply Under evaluation filter

Referral safety status

Yes (68) Apply Yes filter

Referral type

Article 31 referrals Remove Article 31 referrals filter Article 20 procedures Remove Article 20 procedures filter Article 6(12) referrals (prior to January 2010) Remove Article 6(12) referrals (prior to January 2010) filter Article 36 referrals (prior to July 2012) Remove Article 36 referrals (prior to July 2012) filter Article 107i procedures Remove Article 107i procedures filter Article 29(4) referrals (116) Apply Article 29(4) referrals filter Article 30 referrals (93) Apply Article 30 referrals filter Article 107 procedures (prior to July 2012) (15) Apply Article 107 procedures (prior to July 2012) filter Article 29 paediatrics (9) Apply Article 29 paediatrics filter Article 13 referrals (6) Apply Article 13 referrals filter Article 6(13) referrals (prior to January 2010) (5) Apply Article 6(13) referrals (prior to January 2010) filter Article 5(11) referrals (prior to January 2010) (2) Apply Article 5(11) referrals (prior to January 2010) filter

Referral reference number

Referral decision making model

PRAC-CHMP-EC (28) Apply PRAC-CHMP-EC filter PRAC-CMDh (15) Apply PRAC-CMDh filter

Referral authorisation model

Centrally and nationally authorised products (mixed) (10) Apply Centrally and nationally authorised products (mixed) filter Centrally authorised product(s) (20) Apply Centrally authorised product(s) filter Nationally authorised product(s) (22) Apply Nationally authorised product(s) filter

Referral PRAC recommendation

No further action (1) Apply No further action filter Risk minimisation measures (26) Apply Risk minimisation measures filter Suspension (6) Apply Suspension filter Variation (9) Apply Variation filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Date of opinion

From:

To:

Decision date

From:

To:

Medicine type

Accelerated assessment (2) Apply Accelerated assessment filter Additional monitoring (16) Apply Additional monitoring filter Conditional approval (1) Apply Conditional approval filter Exceptional circumstances (1) Apply Exceptional circumstances filter Generic (2) Apply Generic filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

156 results

Remove all filtersRemove all filters

Medicine Referrals Remove Referrals filter

Referral type Article 107i procedures Remove Article 107i procedures filter Article 36 referrals (prior to July 2012) Remove Article 36 referrals (prior to July 2012) filter Article 31 referrals Remove Article 31 referrals filter Article 20 procedures Remove Article 20 procedures filter Article 6(12) referrals (prior to January 2010) Remove Article 6(12) referrals (prior to January 2010) filter

Referral status European Commission final decision Remove European Commission final decision filter

Categories Human Remove Human filter

Sort by

List item

Referral: Bacterial lysates-containing medicinal products indicated for respiratory conditions

Haemophilus influenzae / Klebsiella pneumoniae / Moraxella catarrhalis / Staphylococcus aureus / Streptococcus mitis / S. pneumoniae / S. pyogenes, H. influenzae / K. pneumoniae / M. catarrhalis / Staphylococcus aureus / Streptococcus pneumoniae / S. pyogenes, S. pneumoniae / S. agalactiae / Staphylococcus aureus / H. influenzae, H. influenzae / K. ozaenae / K. pneumoniae / M. catarrhalis / Staphylococcus aureus / Streptococcus pneumoniae / S. pyogenes / S. viridans, H. influenzae / membrane fraction of K. pneumoniae / ribosomal fractions of K. pneumoniae / S. pneumoniae / S. pyogenes, Escherichia coli / K. pneumoniae / S. aureus / S. epidermidis / S. salivarius / S. pneumoniae / S. pyogenes / H. influenzae / Corynebacterium pseudodiphtheriticum / M. catarrhalis, Article 31 referrals
Status: European Commission final decision, opinion/position date: 27/06/2019, EC decision date: 09/09/2019, Last updated: 16/09/2019
List item

Referral: Zinbryta

daclizumab, associated names: Zinbryta, Article 20 procedures
Status: European Commission final decision, EC decision date: 27/03/2018, Last updated: 11/07/2018
List item

Referral: Factor VIII

associated names: Iblias, Elocta, Kovaltry, Nuwiq, Obizur, NovoEight, Voncento, ReFacto AF, Kogenate Bayer, Helixate NexGen, Advate, Article 31 referrals
Status: European Commission final decision, opinion/position date: 14/09/2017, EC decision date: 10/10/2017, Last updated: 05/12/2017
List item

Referral: Micro Therapeutic Research

-, Article 31 referrals
Status: European Commission final decision, opinion/position date: 23/03/2017, EC decision date: 23/06/2017, Last updated: 10/07/2017
List item

Referral: Sibutramine

Sibutramine, Article 31 referrals
Status: European Commission final decision, opinion/position date: 27/06/2002, EC decision date: 26/03/2001, Last updated: 13/12/2002
List item

Referral: Baxter dialysis solutions

Baxter dialysis solutions, Article 31 referrals
Status: European Commission final decision, opinion/position date: 20/10/2011, EC decision date: 16/12/2011, Last updated: 20/11/2013
List item

Referral: Semler

Article 31 referrals
Status: European Commission final decision, opinion/position date: 21/07/2016, EC decision date: 22/09/2016, Last updated: 17/11/2016
List item

Referral: Alkem

Article 31 referrals
Status: European Commission final decision, opinion/position date: 23/06/2016, EC decision date: 08/09/2016, Last updated: 07/10/2016
List item

Referral: Picato

ingenol mebutate, associated names: Picato, Article 20 procedures
Status: European Commission final decision, opinion/position date: 30/04/2020, EC decision date: 06/07/2020, Last updated: 16/11/2020
List item

Referral: Actira

moxifloxacin, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 20/03/2008, EC decision date: 14/07/2008, Last updated: 13/10/2008
List item

Referral: Adrenaline auto-injectors

adrenaline (epinephrine), Article 31 referrals
Status: European Commission final decision, opinion/position date: 25/06/2015, EC decision date: 14/08/2015, Last updated: 26/08/2015
List item

Referral: Agreal

veralipride, Article 31 referrals
Status: European Commission final decision, opinion/position date: 19/07/2007, EC decision date: 01/10/2007, Last updated: 07/01/2008
List item

Referral: Anorectics

amfepramome, clobenzorex, dexfenfluramine, fenbutrazate, fenfluramine, fenproporex, mazindol, mefenorex, norpseudoephedrine, phenmetrazine, phendimetrazine, phentermine and propylhexedrine, Article 31 referrals
Status: European Commission final decision, opinion/position date: 16/02/1996, EC decision date: 09/12/1996, Last updated: 10/12/1996
List item

Referral: Antifibrinolytic medicines

aprotinin, aminocaproic acid, tranexamic acid, Article 31 referrals
Status: European Commission final decision, opinion/position date: 19/06/2012, Last updated: 06/11/2013
List item

Referral: Arcoxia

etoricoxib, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 26/06/2008, EC decision date: 09/09/2008, Last updated: 21/11/2008
List item

Referral: Avelox

moxifloxacin, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 20/03/2008, EC decision date: 14/07/2008, Last updated: 13/10/2008
List item

Referral: Bicalutamide 150 mg

bicalutamide, Article 31 referrals
Status: European Commission final decision, opinion/position date: 24/05/2007, EC decision date: 03/09/2007, Last updated: 03/10/2007
List item

Referral: Bifril, Teoula, Zofepril, Zopranol

zofenopril, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 27/07/2000, EC decision date: 29/11/2000, Last updated: 29/11/2000
List item

Referral: Bisphosphonates

alendronic acid, clodronic acid, etidronic acid, ibandronic acid, neridronic acid, pamidronic acid, risedronic acid, tiludronic acid, zoledronic acid, associated names: Actonel, Aredia, Bonefos, Didronel, Fosamax, Nerixia, Skelid, Article 31 referrals
Status: European Commission final decision, opinion/position date: 14/04/2011, EC decision date: 13/07/2011, Last updated: 28/10/2011
List item

Referral: Bromocriptine-containing medicines indicated in the prevention or suppression of physiological lactation post-partum

bromocriptine, Article 31 referrals
Status: European Commission final decision, opinion/position date: 20/08/2014, EC decision date: 30/10/2014, Last updated: 08/12/2014
List item

Referral: Bupropion hydrochloride

bupropion, Article 36 referrals (prior to July 2012)
Status: European Commission final decision, opinion/position date: 25/07/2002, EC decision date: 25/10/2002, Last updated: 06/12/2002
List item

Referral: Calcitonin

calcitonin, Article 31 referrals
Status: European Commission final decision, opinion/position date: 19/07/2012, EC decision date: 13/02/2013, Last updated: 19/07/2013
List item

Referral: Calcitonins

calcitonin, Article 31 referrals
Status: European Commission final decision, opinion/position date: 22/11/2002, EC decision date: 12/06/2003, Last updated: 02/03/2004
List item

Referral: Cardiostad

lisinopril, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 24/07/2003, EC decision date: 23/02/2004, Last updated: 01/03/2003
List item

Referral: Caustinerf arsenical and Yranicid arsenical

ephedrine hydrochloride, lidocaine and arsenous anhydride, Article 31 referrals
Status: European Commission final decision, opinion/position date: 25/04/2014, EC decision date: 11/07/2014, Last updated: 06/08/2014

Load more

156 results

Referral: Bacterial lysates-containing medicinal products indicated for respiratory conditions

Referral: Zinbryta

Referral: Factor VIII

Referral: Micro Therapeutic Research

Referral: Sibutramine

Referral: Baxter dialysis solutions

Referral: Semler

Referral: Alkem

Referral: Picato

Referral: Actira

Referral: Adrenaline auto-injectors

Referral: Agreal

Referral: Anorectics

Referral: Antifibrinolytic medicines

Referral: Arcoxia

Referral: Avelox

Referral: Bicalutamide 150 mg

Referral: Bifril, Teoula, Zofepril, Zopranol

Referral: Bisphosphonates

Referral: Bromocriptine-containing medicines indicated in the prevention or suppression of physiological lactation post-partum

Referral: Bupropion hydrochloride

Referral: Calcitonin

Referral: Calcitonins

Referral: Cardiostad

Referral: Caustinerf arsenical and Yranicid arsenical